The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (September 2019)
The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here
The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (June 2019)
The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here
The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (March 2019)
The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here
The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (April 2017)
The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people with MS in the United States. Download here
The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (March 2017)
The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people with MS in the United States. Download here
MS Coalition Brochure (January 2012)
The Multiple Sclerosis Coalition (MSC) was founded in 2005 by three independent multiple sclerosis (MS) organizations in an effort to work together to benefit individuals with MS. Since that time, the MSC has grown to nine member organizations, all of whom provide critical MS programs and services. Download here
Thank you for both connecting with & sharing MStranslate as a resource for #RealMSResearch. We look forward to following the exciting #MultipleSclerosis research discoveries continuing to be made by your team. #WorldMSDay #MSConnections https://twitter.com/BrainMind_Usyd/status/1398838585026035712
How well and how safely do the #COVID_19 vaccines work in people with #MS? Join the COVER-MS study and help answer that important question! Learn more and sign up here: http://bit.ly/cover-ms
Authentic representation of #disability in children's books is important! Check out Garrison Redd's #book "Bobby's New Adventure at a New School" to see how Bobby navigates going to school in a #wheelchair for the first time. Click here to order: https://amzn.to/3hucbo8